Dr. Spencer Woolwine, MD

Dr. Woolwine practices at Community Regional Medical Center in Fresno, California, part of Community Health System.

Dr. Woolwine's NPI, 1649665092, was assigned on April 2, 2015. Dr. Woolwine graduated from Un of California, Irvine, College of Medicine in 2015. Dr. Woolwine holds California license A146545.

Dr. Woolwine's primary practice is Community Regional Medical Center, at 2823 Fresno Street, Fresno, CA 93721 in Fresno County. The practice phone is (559) 459-6000.

Dr. Woolwine's primary practice is Community Regional Medical Center in Fresno, California, part of Community Health System. Dr. Woolwine is also affiliated with Emory University Hospital. The medical group on file is Inspire Health Medical Group. Dmand AI also links Dr. Woolwine to 3 more hospitals, 3 medical groups, 2 group practices and clinics, 2 home health agencies, 1 therapy and rehab clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Woolwine practices, 11 sites in all. Vendor and product names are available with a free account.

Adult reconstructive orthopaedic surgery is Dr. Woolwine's primary specialty in the NPI Registry, under taxonomy code 207XS0114X. Dmand AI has Dr. Woolwine's licenses on file in 2 states: California and Georgia.

CMS data shows 1,620 Medicare services from Dr. Woolwine across 13 procedure codes in 2024, for 239 Medicare patients. Medicare paid $41,815 for them. Every service was in an office.

CMS counts 239 Medicare patients who saw Dr. Woolwine in 2024. The largest group is 65 to 74, with 101 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 52% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Woolwine's median patient age at 70, with 56% women.

In 2024, Dr. Woolwine wrote 306 Medicare Part D claims for 84 patients. 99% of them were for generic drugs. CMS names the drug for 274 of them, across 8 drugs with 11 or more claims each, at $7,552 in total drug cost. In 2023, CMS named 226 claims across 10 drugs.

Dr. Woolwine accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Woolwine as offering telehealth. CMS counts 18 procedures of hip replacement by Dr. Woolwine, more than 63% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Woolwine, published from 2012 to 2015. 2014 was the busiest year, with 2. Dr. Woolwine has published most often in J Arthroplasty. Dr. Woolwine's most frequent co-authors are Ran Schwarzkopf, MD, MSc and Behnam Sharareh, MD.

CMS Open Payments shows 7 general payments to Dr. Woolwine from 6 drug and device companies from 2018 to 2023. Education make up the largest share, 77% of the total. Sequoia Surgical, Inc. paid the most, $674.

Dr. Woolwine graduated from Un of California, Irvine, College of Medicine in 2015.